Ischemia/reperfusion-induced MKP-3 impairs endothelial no formation via inactivation of ERK1/2 pathway

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Yang, Dan ^a   Xie, Ping ^a   Liu, Zhihua ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOFURAN DERIVATIVE; DUAL SPECIFICITY PHOSPHATASE 6; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HISTONE DEACETYLASE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE; SALVIANOLIC ACID A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DEACETYLATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; ISCHEMIA; PROMOTER REGION; PROTEIN EXPRESSION; REPERFUSION; UMBILICAL VEIN ENDOTHELIAL CELL;

CAFFEIC ACIDS; DUAL SPECIFICITY PHOSPHATASE 6; ENZYME INDUCTION; HISTONE DEACETYLASE 1; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LACTATES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84864398528     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042076     Document Type: Article

References (51)

1. Moncada S, Palmer RM, (1991) Biosynthesis and actions of nitric oxide. Semin Perinatol 15: 16-19.
2. Moncada S, Palmer RM, Higgs EA, (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
3. Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, et al. (2010) Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 107: 294-304.
4. Sessa WC, (2004) eNOS at a glance. J Cell Sci 117: 2427-2429.
5. Rafikov R, Fonseca FV, Kumar S, Pardo D, Darragh C, et al. (2011) eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. J Endocrinol 210: 271-284.
6. Medhora M, Dhanasekaran A, Pratt PF Jr, Cook CR, Dunn LK, et al. (2008) Role of JNK in network formation of human lung microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 294: L676-685.
7. Kiemer AK, Weber NC, Furst R, Bildner N, Kulhanek-Heinze S, et al. (2002) Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ Res 90: 874-881.
8. Yang D, Xie P, Guo S, Li H, (2010) Induction of MAPK phosphatase-1 by hypothermia inhibits TNF-alpha-induced endothelial barrier dysfunction and apoptosis. Cardiovasc Res 85: 520-529.
9. Rossig L, Hermann C, Haendeler J, Assmus B, Zeiher AM, et al. (2002) Angiotensin II-induced upregulation of MAP kinase phosphatase-3 mRNA levels mediates endothelial cell apoptosis. Basic Res Cardiol 97: 1-8.
10. Whetzel AM, Bolick DT, Hedrick CC, (2009) Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3. Am J Physiol Cell Physiol 296: C339-345.
11. Rossig L, Haendeler J, Hermann C, Malchow P, Urbich C, et al. (2000) Nitric oxide down-regulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis. J Biol Chem 275: 25502-25507.
12. Wang L, Zhou GB, Liu P, Song JH, Liang Y, et al. (2008) Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A 105: 4826-4831.
13. Ho JH, Hong CY, (2011) Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection. J Biomed Sci 18: 30.
14. Schulz R, Kelm M, Heusch G, (2004) Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 61: 402-413.
15. Csonka C, Szilvassy Z, Fulop F, Pali T, Blasig IE, et al. (1999) Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation 100: 2260-2266.
16. Yang D, Guo S, Zhang T, Li H, (2009) Hypothermia attenuates ischemia/reperfusion-induced endothelial cell apoptosis via alterations in apoptotic pathways and JNK signaling. FEBS Lett 583: 2500-2506.
17. Stuehr DJ, (1997) Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol 37: 339-359.
18. Dudzinski DM, Igarashi J, Greif D, Michel T, (2006) The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol 46: 235-276.
19. Searles CD, (2006) Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression. Am J Physiol Cell Physiol 291: C803-816.
20. Tai SC, Robb GB, Marsden PA, (2004) Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel. Arterioscler Thromb Vasc Biol 24: 405-412.
21. Xia R, Zhao B, Wu Y, Hou JB, Zhang L, et al. (2011) Ginsenoside rb1 preconditioning enhances eNOS expression and attenuates myocardial ischemia/reperfusion injury in diabetic rats. J Biomed Biotechnol 2011: 767930.
22. Bauer PM, Fulton D, Boo YC, Sorescu GP, Kemp BE, et al. (2003) Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J Biol Chem 278: 14841-14849.
23. Erwin PA, Lin AJ, Golan DE, Michel T, (2005) Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 280: 19888-19894.
24. Fleming I, (2010) Molecular mechanisms underlying the activation of eNOS. Pflugers Arch 459: 793-806.
25. Haagenson KK, Wu GS, (2010) Mitogen activated protein kinase phosphatases and cancer. Cancer Biol Ther 9: 337-340.
26. Nunes-Xavier C, Roma-Mateo C, Rios P, Tarrega C, Cejudo-Marin R, et al. (2011) Dual-specificity MAP kinase phosphatases as targets of cancer treatment. Anticancer Agents Med Chem 11: 109-132.
27. Koga S, Kojima S, Kishimoto T, Kuwabara S, Yamaguchi A, (2012) Over-expression of map kinase phosphatase-1 (MKP-1) suppresses neuronal death through regulating JNK signaling in hypoxia/re-oxygenation. Brain Res 1436: 137-146.
28. Muda M, Theodosiou A, Rodrigues N, Boschert U, Camps M, et al. (1996) The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem 271: 27205-27208.
29. Furukawa T, Sunamura M, Motoi F, Matsuno S, Horii A, (2003) Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am J Pathol 162: 1807-1815.
30. Furukawa T, Fujisaki R, Yoshida Y, Kanai N, Sunamura M, et al. (2005) Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas. Mod Pathol 18: 1034-1042.
31. Zhou B, Margariti A, Zeng L, Xu Q, (2011) Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis. Cardiovasc Res 90: 413-420.
32. Gan Y, Shen YH, Utama B, Wang J, Coselli J, et al. (2006) Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells. Biochem Biophys Res Commun 340: 29-34.
33. Gan Y, Shen YH, Wang J, Wang X, Utama B, et al. (2005) Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. J Biol Chem 280: 16467-16475.
34. Yang XY, Qiang GF, Zhang L, Zhu XM, Wang SB, et al. (2011) Salvianolic acid A protects against vascular endothelial dysfunction in high-fat diet fed and streptozotocin-induced diabetic rats. J Asian Nat Prod Res 13: 884-894.
35. Zhang YQ, Tang Y, Wu AL, Zhu HB, (2010) Salvianolic acid A displays cardioprotective effects in in vitro models of heart hypoxia/reoxygenation injury. J Asian Nat Prod Res 12: 899-915.
36. Oh KS, Oh BK, Mun J, Seo HW, Lee BH, (2011) Salvianolic acid A suppress lipopolysaccharide-induced NF-kappaB signaling pathway by targeting IKKbeta. Int Immunopharmacol 11: 1901-1906.
37. Pan H, Li D, Fang F, Chen D, Qi L, et al. (2011) Salvianolic acid A demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury. J Cardiovasc Pharmacol 58: 535-542.
38. Fan H, Yang L, Fu F, Xu H, Meng Q, et al. (2012) Cardioprotective effects of salvianolic Acid a on myocardial ischemia-reperfusion injury in vivo and in vitro. Evid Based Complement Alternat Med 2012: 508938.
39. Jiang M, Wang XY, Zhou WY, Li J, Wang J, et al. (2011) Cerebral protection of salvianolic acid A by the inhibition of granulocyte adherence. Am J Chin Med 39: 111-120.
40. Hempel SL, Haycraft DL, Hoak JC, Spector AA, (1990) Reduced prostacyclin formation after reoxygenation of anoxic endothelium. Am J Physiol 259: C738-745.
41. Xie P, Guo S, Fan Y, Zhang H, Gu D, et al. (2009) Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation. J Biol Chem 284: 5488-5496.
42. Fan Y, Xie P, Zhang T, Zhang H, Gu D, et al. (2008) Regulation of the stability and transcriptional activity of NFATc4 by ubiquitination. FEBS Lett 582: 4008-4014.
43. Li HH, Kedar V, Zhang C, McDonough H, Arya R, et al. (2004) Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114: 1058-1071.
44. Li J, Wilson A, Kuruba R, Zhang Q, Gao X, et al. (2008) FXR-mediated regulation of eNOS expression in vascular endothelial cells. Cardiovasc Res 77: 169-177.
45. Reher VG, Zenobio EG, Costa FO, Reher P, Soares RV, (2007) Nitric oxide levels in saliva increase with severity of chronic periodontitis. J Oral Sci 49: 271-276.
46. Liu ZH, Yang D, Xie P, Ren GM, Sun GB, et al. (2012) MiR-106b and MiR-15b Modulate Apoptosis and Angiogenesis in Myocardial Infarction. Cell Physiol and Biochem 29: 851-862.
47. Liu ZH, Chen SL, (2010) ER regulates an evolutionarily conserved apoptosis pathway. Biochem Biophys Res Commun 400(1): 34-38.
48. Liu ZH, Zeng X, Yang D, Ren GM, Chu GY, et al. (2012) Identification of medicinal vines by ITS2 using complementary discrimination methods. J Ethnopharmacol 141: 242-249.
49. Liu ZH, Zeng X, Yang D, Chu GY, Yuan ZR, et al. (2012) Applying DNA barcodes for identification of plant species in the family Araliaceae. Gene 499: 76-80.
50. Zeng X, Yuan ZR, Tong X, Li QS, Gao WW, et al. (2012) Phylogenetic study of Oryzoideae species and related taxa of the Poaceae based on atpB-rbcL and ndhF DNA sequences. Mol Biol Rep 39(5): 5737-5744.
51. Yuan ZR, Chu GY, Dan Y, Li J, Zhang LP, et al. (2012) RCA1: a new candidate gene for bovine mastitis and its association analysis between single nucleotide polymorphisms and milk somatic cell score. Mol Biol Rep 39(6): 6625-6631.